Analyst firms · BofA Securities · PTCT

BofA Securities PTCT price target and rating history

PTC Therapeutics Inc. (PTCT) · Health Care

BofA Securities rates PTC Therapeutics Inc. (PTCT) Buy with a $68 price target, as of its latest action on May 9, 2025. It has published 3 rating actions on PTCT since October 2021, including 2 upgrades and 1 downgrade. Across 8 firms with a PTCT price target in the last 12 months, the median target is $94.50.

Current rating
Buy
Price target
$68
Median target, all firms
$94.50
Actions on PTCT
3

BofA Securities price target on PTCT

$68$53$3820222023202420252026
BofA Securities price target on PTCT, each point a stated target, October 2021 to May 2025.

Every BofA Securities rating on PTCT

How other firms rate PTCT

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Truist SecuritiesHold$62Oct 16, 2026
Leerink PartnersOutperform$98Sep 14, 2026
CitigroupBuy$108Jun 9, 2026
JefferiesBuy$85May 27, 2026
TD CowenBuy$90May 8, 2026
Raymond JamesOutperform$108Apr 10, 2026
BarclaysOverweight$119Jan 28, 2026
RBC Capital MarketsSector Perform$91Dec 1, 2025

Questions about BofA Securities and PTCT

What is BofA Securities's price target for PTCT?
BofA Securities's latest stated price target for PTC Therapeutics Inc. (PTCT) is $68, from its action on May 9, 2025.
What is BofA Securities's rating on PTCT?
BofA Securities rates PTCT Buy, a bullish rating, as of May 9, 2025.
When did BofA Securities last change its view on PTCT?
On May 9, 2025, BofA Securities upgrades to Buy from Neutral, price target $68.
How does BofA Securities's PTCT target compare with other analysts?
Across 8 firms with a PTCT price target in the last 12 months, the median target is $94.50.

More PTCT rating histories

All BofA Securities ratingsPTCT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.